Skip to content

Clinical efficacy of laser assisted ultrasound subgingival scaling in the treatment of chronic periodontitis patients taking anticoagulant drugs

Clinical efficacy of laser assisted ultrasound subgingival scaling in the treatment of chronic periodontitis patients taking anticoagulant drugs

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112006
Enrollment
Unknown
Registered
2025-11-09
Start date
2024-01-02
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal disease

Interventions

Laser group:Ultrasound subgingival scaling+laser treatment
control group:Ultrasound subgingival scaling++sham therapy of laser treatment

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 40-75 years old diagnosed with periodontitis and taking anticoagulant drugs (including warfarin and new oral anticoagulants) for more than 6 months 2. The International Normalized Ratio (INR) is less than or equal to 3.5 3. No periodontal basic treatment has been performed in the past six months, including scaling, scraping, flap surgery and other debridement treatments 4. The cardiovascular disease is in a stable period, meaning that there have been no acute cardiovascular events within 6 months 5. No history of surgery or active bleeding in the past year 6. The patient has clear thinking, unobstructed communication, and high compliance 7. The number of teeth that can be retained on one side of the patient's mouth is greater than or equal to 4 teeth

Exclusion criteria

Exclusion criteria: 1. Cardiac function levels III and IV 2. Blood pressure >= 180/110 mmHg 3. Pregnant women, women in pregnancy or lactation period 4. Those who are currently taking drugs known to affect periodontal tissue or have a history of antibacterial treatment within the past 3 months 5. Patients with uncontrolled and stable systemic diseases, such as progressive liver diseases, infectious diseases, severe trauma, renal failure, rheumatoid arthritis, blood system diseases, mental diseases, diabetes, etc 6. Patients with malignant tumors or undergoing radiotherapy, chemotherapy, and targeted drug therapy 7. Patients with pacemakers who cannot undergo ultrasound therapy 8. Smoking or quitting smoking for less than 5 years 9. Patients receiving treatment with bisphosphonates

Design outcomes

Primary

MeasureTime frame
probing depth;

Secondary

MeasureTime frame
clinical attachment level;plaque index;bleeding index;number of loosen teeth;postoperative bleeding indicators;Gum color;Comfort level of treatment;tooth sensitivity;

Countries

China

Contacts

Public ContactLei Lihong

The Second Affiliated Hospital of Zhejiang University School of Medicine

zjullh@zju.edu.cn+86 139 8946 3654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026